Pyrazole derivatives having a pyridazine and pyridine...

Details Pyrazole derivatives having a pyridazine and pyridine... Pyrazole derivatives having a pyridazine and pyridine...

2004-02-06

2009-11-24

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S224000

Reexamination Certificate

active

07622471

ABSTRACT:
The present invention is directed to a strong platelet aggregation-inhibiting agent which does not inhibit COX-1 or COX-2. Further, the present invention provides compounds represented by formula (I), salts of the compounds, and solvates or hydrates of the compounds or the salts. Also provided are medicaments containing any of the compounds, salts, or solvates and preventive and/or therapeutic agents for ischemic diseases, containing any of the compounds, salts, or the solvates or hydrates.

REFERENCES:
patent: 5134142 (1992-07-01), Matsuo et al.
patent: 5217971 (1993-06-01), Takasugi et al.
patent: 5229386 (1993-07-01), Takasugi et al.
patent: 5401700 (1995-03-01), Sohn et al.
patent: 5420141 (1995-05-01), Boigegrain et al.
patent: 5556987 (1996-09-01), Aoki et al.
patent: 5616592 (1997-04-01), Boigegrain et al.
patent: 5624941 (1997-04-01), Barth et al.
patent: 5635526 (1997-06-01), Boigegrain et al.
patent: 5744491 (1998-04-01), Boigegrain et al.
patent: 5854265 (1998-12-01), Anthony
patent: 6306883 (2001-10-01), Adams et al.
patent: 6407259 (2002-06-01), Harris et al.
patent: 6436966 (2002-08-01), Ohkawa et al.
patent: 6620825 (2003-09-01), Ohkawa et al.
patent: 6699991 (2004-03-01), James et al.
patent: 6962933 (2005-11-01), Ohkawa et al.
patent: 2003/0144309 (2003-07-01), Choon-Moon
patent: 2006/0189591 (2006-08-01), Okayama et al.
patent: 0 418 845 (1991-03-01), None
patent: 0 987 253 (2000-03-01), None
patent: 1 104 758 (2001-06-01), None
patent: 1 142 889 (2001-10-01), None
patent: 44532 (1986-06-01), None
patent: 50 121269 (1975-09-01), None
patent: 61 40266 (1986-02-01), None
patent: 8 12654 (1996-01-01), None
patent: 9 227555 (1997-09-01), None
patent: 2005-022972 (2005-01-01), None
patent: 93 14062 (1993-07-01), None
patent: 97 03973 (1997-02-01), None
patent: 97 36897 (1997-10-01), None
patent: 97/49698 (1997-12-01), None
patent: 98 52937 (1998-11-01), None
patent: 98 52940 (1998-11-01), None
patent: 98 52941 (1998-11-01), None
patent: 98 56377 (1998-12-01), None
patent: 99 51580 (1999-10-01), None
patent: 99 58523 (1999-11-01), None
patent: 00 63204 (2000-10-01), None
patent: 01 16132 (2001-03-01), None
patent: WO 01/19788 (2001-03-01), None
patent: WO 01/19798 (2001-03-01), None
patent: 01 40216 (2001-06-01), None
patent: 01 58869 (2001-08-01), None
patent: 01 64642 (2001-09-01), None
patent: 01 87880 (2001-11-01), None
patent: 01 90078 (2001-11-01), None
patent: 02 04424 (2002-01-01), None
patent: 02 067683 (2002-09-01), None
patent: 02/085897 (2002-10-01), None
patent: WO 02/092593 (2002-11-01), None
patent: 03 027076 (2003-04-01), None
patent: 03 031435 (2003-04-01), None
patent: 03 037274 (2003-05-01), None
patent: 03 040110 (2003-05-01), None
patent: 03 051841 (2003-06-01), None
patent: 03 051842 (2003-06-01), None
patent: 03 051873 (2003-06-01), None
patent: WO 2004/050632 (2004-06-01), None
patent: WO 2004/089937 (2004-10-01), None
patent: WO 2005/063736 (2005-07-01), None
Vippagunta et al. Advanced Drug Delivery Reviews, 2001, 48, 3-26.
“National library of medicine”, http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi, accessed Jul. 23, 2008.
Arnould er al. The American Journal of Pathology, 2001, 1591(1), 345-57.
U.S. Appl. No. 10/553,982, filed Oct. 20, 2005, Okayama, et al.
U.S. Appl. No. 10/584,632, filed Jun. 26, 2006, Kanaya, et al.
U.S. Appl. No. 11/571,387, filed Dec. 28, 2006, Kanaya, et al.
U.S. Appl. No. 11/659,086, filed Feb. 1, 2007, Sato, et al.
U.S. Appl. No. 11/573,098, filed Feb. 2, 2007, Kanaya, et al.
Penning et al. “Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)”, J. Med. Chem., vol. 40, pp. 1347-1365 1997.
Lan et al. “Structure-Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor Antagonists”, J. Med. Chem., vol. 42, pp. 769-776 1999.
Tanaka et al. “Antiplatelet Agents Based on Cyclooxygenase Inhibition without Ulcerogenesis. Evaluation and Synthesis of 4,5-Bis(4-methoxyphenyl)-2-substituted-thiazoles”, J. Med. Chem., vol. 37, pp. 1189-1199 1994.
Dohi et al. “The anti-platelet actions of FR122047, a novel cyclooxygenase inhibitor”, European Journal of Pharmacology, vol. 243, pp. 179-184 1993.
Ochi et al. “The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models”, European Journal of Pharmacology, vol. 391, pp. 49-54 2000.
Rynbrandt et al. “Synthesis and Platelet Aggregation Inhibitory Activity of 4,5-Bis(aryl)-2-substituted-thiazoles”, J. Med. Chem., vol. 24, pp. 1507-1510 1981.
Tsuji et al. “Studies on Anti-inflammatory Agents. IV. Synthesis and Pharmacological Properties of 1,5-Diarylpyrazoles and Related Derivatives”, Chem. Pharm. Bull, vol. 45, No. 6, pp. 987-995 1997.
Takahashi et al. “FR167653, a p38 Mitogen-Activated Protein Kinase Inhibitor, Prevents Helicobacter pylori-Induced Gastritis in Mongolian Gerbils”, Journal of Pharmacology and Experimental Therapeutics, vol. 296, No. 1, pp. 48-56 2001.
Dannhardt et al. “Cyclooxygenase inhibitors—current status and future prospects”, Eur. J. Med. Chem., vol. 36, pp. 109-126 2001.
Hawkey. “COX-2 Inhibitors”, The Lancet, vol. 353, pp. 307-314 1999.
Tanaka et al. “Studies on Anti-platelet Agents. V. Synthesis and Structure-Activity Relationship of 3-Substituted 5,6-Bis(4-methoxyphenyI)-1,2,4-triazines”, Chem. Pharm. Bull., vol. 42, No. 9, pp. 1835-1840 1994.
Tanaka et al. “Studies on Anti-platelet Agents. IV. A Series of 2-Substituted 4,5-Bis(4-methoxyphenyl)pyrimidines as Novel Anti-platelet Agents”, Chem. Pharm. Bull., vol. 42, No. 9, pp. 1828-1834 1994.
Kanebo et al. “Pamicogrel Paminate”, Drugs of the Future, vol. 26, No. 2, p. 197 2001.
“2-[4,5-Bis(4-methoxypheny)thiazol-2-yl]pyrrole-1-acetic acid ethyl ester”, Drugs of the Future, vol. 16, No. 2, pp. 105-107 1991.
Tanemoto et al. “Clinical Study of KBT-3022: Platelet Aggregation Effects and Pharmacokinetics in Elderly (>65 Years of Age) and Nonelderly Patients with Chronic Arterial Occlusion”, Current Therapeutic Research, vol. 61, No. 12, pp. 891-900 2000.
Inoue et al. “Synthesis and Antiplatelet Activity of 2-Amino-4,5-diphenylthiazole Derivatives”, Yakugaku Zasshi, vol. 115, No. 8, pp. 603-610, with English abstract 1995.
“Collaborative overview of randomiSed trials of antiplatelet therapy- I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients”, BMJ, vol. 308, pp. 81-106 1994.
Derry et al. “Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis”, BMJ, vol. 321, pp. 1183-1187 2000.
Catella-Lawson. “Vascular biology of thrombosis”, Neurology, vol. 57, suppl. 2, pp. S5-S7 2001.
Pairet et al. “Measurement of Differential Inhibition of COX-1 and COX-2 and the Pharmacology of Selective Inhibitors”, Drugs of Today, vol. 35, pp. 251-265 1999.
New Current 12 (27), Dec. 10, 2001, Report of Research and Development (w/ English Translation).
Robert W. Hamilton, “The Antiarrhythmic and Antiinflammatory Activity of a Series of Tricyclic Pyrazoles” Journal of Heterocyclic Chemistry, Provo UT, US, vol. 13, No. 3, Jun. 1976, pp. 545-553.

Affiliated with

Also associated with

Rating

Pyrazole derivatives having a pyridazine and pyridine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazole derivatives having a pyridazine and pyridine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivatives having a pyridazine and pyridine... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4074712